Hyaluronic-acid filler family

Revanesse Fillers

An FDA-approved family of hyaluronic-acid fillers used for moderate-to-severe nasolabial folds (Versa) and for lip volume (Lips+). Smoother, less swelling-prone than some peer products in the same indication.

[ Revanesse Versa ][ Revanesse Lips+ ]
Book a consultation
A Southern Vanity clinician treating a patient
Duration
30–45 min
Onset
Immediate (final at 2 weeks)
Lasts
6–12 months
Downtime
Mild swelling 1–3 days; bruising possible

What it is

Revanesse is an FDA-approved family of hyaluronic-acid dermal fillers. The two products we use most:

  • Revanesse Versa — indicated for moderate-to-severe nasolabial folds. Known clinically for a smoother integration profile with less post-treatment swelling than several peer products.
  • Revanesse Lips+ — indicated for lip augmentation. Soft enough for natural movement; suited to patients who want lip volume without dramatic enhancement.

How we approach it

Versa suits the patient whose nasolabial folds have moved past topical-care range and who is sensitive to the swelling that some other HA fillers produce. Lips+ is a soft, natural-movement option for lip patients — comparable in feel to Juvéderm Volbella, with slightly different molecular characteristics.

The injector selects between Revanesse and the Juvéderm family based on tissue type, your prior response to filler, and the specific contour being addressed.

What to expect

Volume immediate; mild swelling for one to three days; final shape at two weeks. Duration six to twelve months per syringe.

Candidacy

Good for moderate nasolabial folds or lip refinement, particularly in patients who want softer post-treatment swelling. Not for deep structural volume loss, pregnancy, or active facial infection.

Who it suits

[ Indicated for ]
  • Moderate-to-severe nasolabial folds (Versa)
  • Lip volume and definition (Lips+)
  • Patients sensitive to post-treatment swelling
[ Not a candidate if ]
  • Deep structural volume loss — Voluma or Sculptra suit better
  • Pregnant or nursing patients
  • Patients with active facial infection
[ Before your visit ]
  • Bruising at entry points is the most common side effect
  • Final shape at two weeks; do not assess the day of treatment
Consultation

Begin with a conversation.

Every plan is drawn before it is performed. The clinician will tell you what is possible, and what is not.